Skip to main content
Caplight Logo









ImmuneAGE Bio

ImmuneAGE Bio

Private
LausanneHealthcare & Life Scienceshttps://immuneage.bio

Last Round

Seed

Jul 12, 2024

Total Funding Raised

$2.05M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ImmuneAGE Bio is a biotechnology company that provides a drug discovery platform focused on rejuvenating the immune system by targeting hematopoietic stem cells.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

hematopoietic stem cellsHSCimmune rejuvenationlongevity biotechdrug discovery platformex vivo expansionsmall-molecule therapeuticsbone marrow transplantationanti-aging therapycell therapyinvestigational new drugINDregenerative medicinechemotherapy recovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ImmuneAGE Bio Comparables

Compare ImmuneAGE Bio with similar companies based on industry and business-model similarity.

ImmuneAGE Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mogling Bio Inc.
85%
HexemBio
85%
ExCellThera
78%

ImmuneAGE Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 12, 2024
Pre SeedMay 10, 2023

ImmuneAGE Bio Investors

Notable investors and investment history

ImmuneAGE Bio investors
InvestorRounds
1517 FundSeed
VitaDAOPre Seed, Seed
Infinita FundSeed
Healthspan CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 1288% MoM, reaching 958.

  • Mar 4, 2026

    Monthly visitors grew 108% MoM, reaching 1.2K.

ImmuneAGE Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ImmuneAGE Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ImmuneAGE Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLausanne
Employee Range1
Year Founded2022
Last FundingJul 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?